Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation

Abstract

We describe two patients who developed respiratory syncytial virus (RSV) pneumonia after BMT. One died of RSV pneumonia after three courses of steroid pulse therapy. Surprisingly, RSV antigen was identified in the bronchoalveolar lavage fluid (BALF) obtained post mortem. Steroid pulse therapy might have suppressed anti-RSV immunity, leading to persistent RSV infection for more than 1 month. The other patient received donor lymphocyte infusions (DLI) for relapsed plasma cell leukemia, while having active RSV pneumonia. His respiratory condition improved after DLI, and RSV antigen disappeared in BALF and nasal swabs. DLI might be effective in cases of life-threatening RSV pneumonia. Bone Marrow Transplantation (2000) 26, 573–576.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. McCarthy AJ, Kingman HM, Kelly C et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation Bone Marrow Transplant 1999 24: 1315–1322

    Article  CAS  PubMed  Google Scholar 

  2. Whimbey E, Champlin RE, Couch RB et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients Clin Infect Dis 1996 22: 778–782

    Article  CAS  PubMed  Google Scholar 

  3. Subbarao EK, Dietrich MC, De Sierra TM et al. Rapid detection of respiratory syncytial virus by a biotin-enhanced immunoassay: test performance by laboratory technologists and housestaff Pediatr Infect Dis J 1989 8: 865–869

    Article  CAS  PubMed  Google Scholar 

  4. Freymuth F, Eugene G, Vabret A et al. Detection of respiratory syncytial virus by reverse transcription-PCR and hybridization with a DNA enzyme immunoassay J Clin Microbiol 1995 33: 3352–3355

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Whimbey E, Champlin RE, Englund JA et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients Bone Marrow Transplant 1995 16: 393–399

    CAS  PubMed  Google Scholar 

  6. Englund JA, Sullivan CJ, Jordan MC et al. Respiratory syncytial virus infection in immunocompromised adults Ann Intern Med 1988 109: 203–208

    Article  CAS  PubMed  Google Scholar 

  7. Lewinsohn DM, Bowden RA, Mattson D, Crawford SW . Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation Antimicrob Agents Chemother 1996 40: 2555–2557

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Bowden RA . Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience Am J Med 1997 102: (3A) 27–30

    Article  CAS  PubMed  Google Scholar 

  9. Alwan WH, Record FM, Openshaw PJ . CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells Clin Exp Immunol 1992 88: 527–536

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. van Woensel JB, Wolfs TF, van Aalderen WM et al. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis Thorax 1997 52: 634–637

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Bulow SM, Nir M, Levin E et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants Pediatrics 1999 104: 77

    Article  Google Scholar 

  12. Papadopoulos EB, Ladanyi M, Emanuel D et al. Infusions of donor leukocytes to treat Epstein–Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation New Engl J Med 1994 330: 1185–1191

    Article  CAS  PubMed  Google Scholar 

  13. Hromas R, Cornetta K, Srour E et al. Donor leukocyte infusion as therapy of life-threatening adenoviral infections after T-cell-depleted bone marrow transplantation (letter) Blood 1994 84: 1689–1690

    CAS  PubMed  Google Scholar 

  14. Ilan Y, Nagler A, Shouval D et al. Development of antibodies to hepatitis B virus surface antigen in bone marrow transplant recipient following treatment with peripheral blood lymphocytes from immunized donors Clin Exp Immunol 1994 97: 299–302

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ilan Y, Nagler A, Adler R et al. Ablation of persistent hepatitis B by bone marrow transplantation from a hepatitis B-immune donor Gastroenterology 1993 104: 1818–1821

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kishi, Y., Kami, M., Oki, Y. et al. Donor lymphocyte infusion for treatment of life-threatening respiratory syncytial virus infection following bone marrow transplantation. Bone Marrow Transplant 26, 573–576 (2000). https://doi.org/10.1038/sj.bmt.1702559

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702559

Keywords

This article is cited by

Search

Quick links